ERYTECH Pharma S.A.
ERYP · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $9,562 | $48,962 | $138,858 | $117,965 |
| - Cash | $38,789 | $33,699 | $44,446 | $73,173 |
| + Debt | $13,567 | $25,375 | $27,448 | $14,124 |
| Enterprise Value | -$15,660 | $40,638 | $121,860 | $58,916 |
| Revenue | $0 | $0 | $0 | $3,364 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | -$57,580 | -$48,829 |
| % Margin | – | – | – | -1,451.5% |
| EBITDA | -$22,694 | -$46,280 | -$67,054 | $11,177 |
| % Margin | – | – | – | 332.3% |
| Net Income | -$228 | -$53,797 | -$73,300 | -$62,659 |
| % Margin | – | – | – | -1,862.6% |
| EPS Diluted | -0.007 | -2.27 | -3.99 | -3.49 |
| % Growth | 99.7% | 43.1% | -14.3% | – |
| Operating Cash Flow | -$31,764 | -$56,770 | -$51,720 | -$43,310 |
| Capital Expenditures | -$85 | -$298 | -$1,141 | -$20,133 |
| Free Cash Flow | -$31,849 | -$57,068 | -$52,861 | -$63,443 |